Yes, regular follow-up appointments are recommended, typically every 4-8 weeks during initial dose titration of weight loss medications
GLP-1 medications, including the oral semaglutide pill, are generally well-tolerated by many patients
Injections can improve nerve health, reducing symptoms of nerve damage such as numbness, tingling, and muscle weakness, which are commonly experienced in conditions like peripheral neuropathy
By preventing NF-kB activation increase and its binding to DNA, TQ reduces neuroinflammation
Neuropharmacology (2014) 86:2230
Research Applications & Contexts Cagrilintide is being investigated across multiple research contexts focused on metabolic regulation, weight management, and glucose homeostasis